Korean J Urol.
2001 Jun;42(6):615-620.
The Clinical Effects of Amitriptyline in Patients with Urinary Frequency and Chronic Pelvic Pain Syndrome
- Affiliations
-
- 1Department of Urology, Keimyung University School of Medicine, Daegu,
Korea.
Abstract
-
PURPOSE: We evaluated the effects of amitriptyline in patients with urinary frequency
or pelvic pain syndrome and compared with propiverine hydrochloride (BUP-4(R)) and
diazepam (Valium(R)).
MATERIALS AND METHODS
One-hundred and sixty-eight patients with urinary frequency
or pain were included and 38 out of 168 patients were lost to follow up. The patients
with interstitial cystitis, UTI and neurogenic bladder were excluded. Amitriptyline group
were instructed to take 25mg to 75mg of amitriptyline before bed. Propiverine hy
drochloride and diazepam group were instructed to take 20mg, 4-6mg before bed,
respectively. The clinical effects and side effects were evaluated after 4 weeks of
medication.
RESULTS
In the amitriptyline group, 73.1% in 78 patients with frequency, 68.3% in 60
pain, 65.6% in 32 nocturia, 53.8% in 26 weak urinary stream, 53.8% in 13 dysuria,
72.7% in 11 urgency showed symptom improvement. Urinary frequency and pain score
were significantly decreased in the amitriptyline group. In the propiverine hydrochloride
group, 66.7% in 21 patients with frequency, 38.8% in 18 pain showed symptom
improvement. In the diazepam group, 37.5% in 24 patients with frequency, 31.3% in
16 pain showed symptom improvement. Side effects of amitriptyline had appeared in
24 (27.6%) out of 87 patients; 17 cases of dry mouth, 10 drowsiness, 2 agitation, 2
nausea, 1 constipation and 1 skin rash.
CONCLUSIONS
Amitriptyline is useful in vague voiding symptoms especially in urinary
frequency and chronic pelvic pain syndrome. It is equally effective in both men and
women. Side effects are minimal and tolerable. A double-blind placebo-controlled trial
is necessary for general acceptance in the future.